Prevalence and management of arterial hypertension in the population aged 25–64 in the Czech Republic with a focus on diabetic patients

Česká verze

Authors: V. Vejtasová ¹; M. Lustigová ^2,5; J. Urbanová ³; K. Žejglicová ²; J. Malinovská ⁴; D. Janíčková Žďárská ⁴; L. Brunerová ³; K. Kučera ⁶; J. Brož ⁴
Authors place of work: Kardiologická klinika 2. LF UK a FN v Motole, Praha ¹; Státní zdravotní ústav, Praha ²; Interní klinika 3. LF UK a FNKV, Praha ³; Interní klinika 2. LF UK a FN v Motole, Praha ⁴; Přírodovědecká fakulta UK, Praha ⁵; Klinikum Darmstadt GmbH, Darmstadt, Německo ⁶
Published in the journal: Epidemiol. Mikrobiol. Imunol. 70, 2021, č. 4, s. 247-252
Category: Původní práce

Summary

Objective: The aim of the study was to determine the prevalence of arterial hypertension and its awareness rate and control rate among diabetes mellitus (DM) patients in the Czech Republic between 25–64 years of age and to compare the results with those in age-matched non-diabetic patients.

Materials and methods: Blood pressure measurement data of 1 170 respondents (467 men and 703 women) obtained during the EHES study in 2014 were analysed. DM was diagnosed in 95 (8.2%) respondents (44 men and 51 women).

Results: Mean systolic blood pressure in DM patients was 130.7 ± 18.3 vs. 123.2 ± 16.8 mmHg in non-DM subjects (p < 0.001). The difference in diastolic blood pressure was on the borderline of statistical significance (82.2 ± 9.4 mmHg in DM vs. 80.0 ± 10.6 mmHg in non-DM subjects, p = 0.051). Among the study population, 69.5% of DM and 34.2% of non-DM subjects suffered from arterial hypertension (p < 0.001). The hypertension awareness rates were 87.9% in the DM group and 66.8 % in the non-DM group. (p = 0.001). The percentage of treated arterial hypertension was 94.8% in DM patients vs. 80.5% in the non-DM group (p = 0.010). The blood pressure target of < 140/90 mmHg was achieved in 47.3% of DM patients vs. 60.6% in non-DM subjects (p = 0.077). Using a blood pressure target of < 130/80 mmHg, adequate arterial hypertension control was achieved in only 29.1% of DM patients. When comparing the achievement of the blood pressure targets recommended for diabetic patients (< 130/80 mmHg) and non-DM patients (< 140/90 mmHg), the difference between these groups was statistically significant (p < 0.001) in favour of the non-diabetic group.

Conclusion: The study has shown the prevalence of arterial hypertension to be twice as high in DM patients aged 25–64 compared to the age-matched non-DM subjects in the Czech Republic. The adequate blood pressure control rate is significantly lower in DM patients than in the non-diabetic population. The study results indicate that the blood pressure targets recommended for diabetic patients (< 130/80 mmHg) are not always reached in clinical practice.

Keywords:

arterial hypertension – Czech population – diabetes mellitus – adequate blood pressure control

Zdroje

1. Mills KT, Bundy JD, Kelly TN, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation, 2016;134(6):441–450.

2. Cífková R, Bruthans J, Wohlfahrt P, et al. Prevalence hlavních rizikových faktorů kardiovaskulárních onemocnění v české populaci v letech 2015–2018. Studie Czech post-MONICA. Cor Vasa, 2020;62:6–15.

3. ATLAS, IDF Diabetes. Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract, 2017;128:40– 50.

4. Prevalence diabetu mellitu: Prevalence diabetu mellitu v roce 2016 v ČR absolutně a na 1 000 obyvatel [online]. In: ÚZIS ČR, Výkaz ambulantní péče A004, 2017 [cit. 2020-03-29]. Dostupné na www: https://reporting.uzis.cz/cr/index.php?pg=statisticke- vystupy--morbidita--intervalova-prevalence-dle-diagnoz-prevalence-diabetu-mellitu.

5. Council ES, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Eur Heart J, 2013;34:2159–2219.

6. Widimský J jr., Filipovský J, Ceral J, a spol. Diagnostické a léčebné postupy u arteriální hypertenze – verze 2017. Doporučení České společnosti pro hypertenzi. Hypertenze KV prevence, 2018;7(Supl):1–20.

7. Morrish NJ, Steven LK, Head J, et al. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: associated risk factorin. Diabetologia, 1990;33.9:542–548.

8. Žejglicová K, Kratěnová J, Lustigová M, et al. Vybrané ukazatele zdravotního stavu české populace – výsledky studie EHES 2014. Prakt Lék, 2017;97(3):123–130.

9. Tolonen H, Koponen P, Al-kerwi A, et al. European health examination surveys–a tool for collecting objective information about the health of the population. Arch Public Health, 2018;76(1):38.

10. World Health Organization, et al. International Society of Hypertension guidelines for the management of hypertension: guidelines subcommittee. J Hypertens, 1999;17:151–183.

11. World Health Organization. World health statistics 2015.

12. Mushtaq M, Najam N. Depression, anxiety, stress and demographic determinants of hypertension disease. Pak J Med Sci, 2014;30(6):1293.

13. Stockwell DH, Madhavan S, Cohen H, et al. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health,1994;84(11):1768–1774.

14. Rückert IM, Baumert J, Schunk M, et al. Blood pressure control has improved in people with and without type 2 diabetes but remains suboptimal: a longitudinal study based on the German DIAB-CORE consortium. PloS One, 2015;10(7):e0133493.

15. Menéndez E, Delgado E, Fernández-Vega F, et al. Prevalence, diagnosis, treatment, and control of hypertension in Spain. Results of the Di@bet.es study. Rev Esp Cardiol, 2016;69(6):572–578.

16. Brown MJ, Castaigne A, De Leeuw PW, et al. Influence of diabetes and type of hypertension on response to antihypertensive treatment. Hypertension, 2000;35.5: 1038–1042.

17. Fábryová MĽ. Artériová hypertenzia a diabetes mellitus – pohľad diabetológa. Via Pract, 2011;8(4),156–160.

18. Libianto R, Batu D, MacIsaac RJ, et al. Pathophysiological links between diabetes and blood pressure. Can J Cardiol, 2018;34(5):585–594.

19. Bittnerová M, Vojčíková A, Magulová L, et al. Porovnanie klinického stavu a farmakoterapie u pacientov s hypertenziou a súčasne s diabetom mellitom a pacientov s hypertenziou bez diabetu. Klin Farmakol Farm, 2006;20:123–128.

20. Bullard KM, Cowie CC, Lessem SE, et al. Prevalence of Diagnosed Diabetes in Adults by Diabetes Type – United States, 2016. MMWR Morbidity Mortal Wkly Rep, 2018;67:359–361.

21. Urbanova J, Brunerova L, Broz J. How can maturity-onset diabetes of the young be identified among more common diabetes subtypes? Wien Klin Wochenschr, 2019;131:435–441.

22. Brož J, Malinovská J, Nunes MA, et al. Prevalence of diabetes and prediabetes and its risk factors in adults aged 25-64 in the Czech Republic: A cross-sectional study. Diabetes Res Clin Pract, 2020;170:108470.

23. Van Buren PN, Toto R. Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis, 2011;18:28–41.